Tesamorelin 10mg Dosage Guide
Tesamorelin 10mg dosage is a common search because many people see vial strength, daily dosage, and reconstitution instructions discussed online and assume they are the same thing. They are not. Tesamorelin is a prescription peptide that affects growth hormone and IGF 1 signaling, so dosing should be based on the exact formulation, medical history, and provider guidance.
In the United States, FDA approved tesamorelin is used to reduce excess abdominal fat in adults with HIV associated lipodystrophy, and it is not approved for general weight loss management.
Read our Tesamorelin 10mg Complete Guide for a broader overview before reviewing dosage.
Tesamorelin Dosage Overview
The dosage of tesamorelin peptide depends on the prescribed product. Current US labeling separates EGRIFTA SV and EGRIFTA WR, and these formulations are not substitutable. That means a person should not switch between products, vial sizes, or injection volumes without medical instruction.
| Product | Common Labeled Daily Dose | Injection Route | Important Note |
| EGRIFTA SV | 1.4 mg once daily | Subcutaneous injection | Inject into the abdomen and rotate sites |
| EGRIFTA WR | 1.28 mg once daily | Subcutaneous injection | One reconstituted vial provides 7 daily doses |
| Tesamorelin 10mg vial | Depends on concentration and instructions | Subcutaneous injection | Do not calculate dose from vial size alone |
People researching Tesamorelin 10mg should understand that “10mg” usually refers to vial strength, not automatically the daily dose.
Tesamorelin Peptide Dosage Chart
A tesamorelin peptide dosage chart can be helpful for education, but it should not replace medical instructions. The key is knowing the difference between milligrams, milliliters, concentration, and reconstitution volume.
Tesamorelin Dosing Terms
| Term | What It Means |
| Vial strength | Total amount of tesamorelin in the vial |
| Daily dose | Amount prescribed per day |
| Injection volume | Liquid amount drawn into the syringe |
| Reconstitution | Mixing the peptide with the correct diluent |
| Frequency | How often the dose is taken |
Read Tesamorelin 10mg Reconstitution for preparation details.
Tesamorelin Dosage Per Day
The tesamorelin dosage per day in FDA-approved labeling is once daily subcutaneous injection.
- EGRIFTA SV: 1.4 mg daily
- EGRIFTA WR: 1.28 mg daily
Increasing the dose beyond prescribed levels does not accelerate results and may increase risks related to IGF-1 elevation, fluid retention, joint discomfort, or glucose imbalance.
See How Tesamorelin Works to understand why dosing impacts hormone pathways.
Tesamorelin Peptide Dosage for Weight Loss
There is no approved tesamorelin peptide dosage for weight loss. This is important because many online searches mention a “tesamorelin dosage calculator for weight loss,” but tesamorelin is not FDA approved for general obesity treatment or cosmetic fat loss.
Its approved role is specific to excess abdominal fat in adults with HIV associated lipodystrophy. If your goal is body composition, read Tesamorelin for Weight Loss to understand the difference between visceral fat discussions and regular weight loss claims.
How to Take Tesamorelin Dosage Safely
Tesamorelin is taken by subcutaneous injection, usually into the abdomen for approved formulations. Injection sites should be rotated, and users should avoid areas with scars, bruising, irritation, or the navel area. The solution should also be checked before use when labeling requires inspection.
Safe Administration Guidelines
- Following the prescribed formulation exactly
- Using the correct reconstitution instructions
- Measuring the dose carefully
- Rotating injection sites
- Tracking side effects
- Monitoring labs when recommended
Review possible Tesamorelin Side Effects before starting the dose.
Who Should Manage Tesamorelin Dosage?
Tesamorelin dosing should always be managed by a qualified healthcare provider. It may be considered for patients who:
- Have diagnosed HIV-associated lipodystrophy
- Require visceral fat reduction under supervision
- Are undergoing metabolic or endocrine evaluation
It is not intended for general fitness, bodybuilding, or aesthetic fat loss use.
Conclusion
The correct tesamorelin 10mg dosage is not something that can be calculated from online charts or vial size alone. FDA-approved dosing is specific, medically regulated, and tied to a defined clinical condition.
Tesamorelin should always be used under professional supervision with attention to formulation, dosing accuracy, and metabolic monitoring. If you are considering it, the safest approach is to consult a healthcare provider and follow a structured, evidence-based protocol.
FAQs
Q: What is tesamorelin dosage?
A: Tesamorelin dosage depends on the formulation. EGRIFTA SV is labeled as 1.4 mg once daily, while EGRIFTA WR is labeled as 1.28 mg once daily.
Q: What is the dosage for tesamorelin peptide?
A: The dosage should be based on the prescribed product, concentration, reconstitution, and provider instructions.
Q: How to take tesamorelin dosage?
A: Tesamorelin is taken by subcutaneous injection, commonly into the abdomen, with injection site rotation.
Q: What is the recommended dosage for tesamorelin?
A: Approved dosing varies by product. Do not substitute one formulation for another without medical guidance.
Q: Is there a tesamorelin dosage calculator for weight loss?
A: No approved dosage calculator exists for weight loss because tesamorelin is not approved for general weight loss.
References
- DailyMed: EGRIFTA SV Prescribing Information
- DailyMed: EGRIFTA WR Prescribing Information
- FDA: EGRIFTA WR Full Prescribing Information
- MedlinePlus: Tesamorelin Injection
- Mayo Clinic: Tesamorelin Subcutaneous Route
If you found this guide helpful, consider exploring a high-quality option and feel free to review the product to share your experience with others.